Khaled Abdelgawwad Selected Research

Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)

5/2024	Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study.
2/2024	Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low Molecular Weight Heparin - The OSCAR-UK Study.
4/2023	Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism.
1/2023	Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US Program.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Khaled Abdelgawwad Research Topics

Disease

9	Venous Thromboembolism 05/2024 - 02/2021
9	Hemorrhage 05/2024 - 01/2021
8	Neoplasms (Cancer) 05/2024 - 02/2021
5	Atrial Fibrillation 03/2024 - 01/2021
3	Embolism (Embolus) 03/2024 - 01/2021
2	Renal Insufficiency (Renal Failure) 03/2024 - 01/2023
2	Ischemic Stroke 03/2024 - 02/2024
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2024 - 01/2021
2	Stroke (Strokes) 02/2024 - 01/2021
2	Thrombosis (Thrombus) 04/2023 - 12/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2021
1	Leukemia 07/2023
1	Acute Kidney Injury (Acute Renal Failure) 01/2023
1	Chronic Renal Insufficiency 01/2023
1	Pulmonary Embolism 12/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2021
1	Thromboembolism 01/2021

Drug/Important Bio-Agent (IBA)

14	RivaroxabanIBA 05/2024 - 01/2021
5	Warfarin (Coumadin)FDA LinkGeneric 02/2024 - 01/2021
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2024 - 01/2023
4	AnticoagulantsIBA 03/2024 - 02/2021
4	apixabanIBA 03/2024 - 10/2021
2	Factor Xa InhibitorsIBA 02/2024 - 04/2023
1	Phenprocoumon (Liquamar)FDA Link 03/2024
1	Vitamin K FDA Link 03/2024
1	Factor Xa (Coagulation Factor Xa)IBA 03/2024
1	Dabigatran FDA Link 02/2024
1	CreatinineIBA 01/2023

Therapy/Procedure

2	Therapeutics 12/2021 - 02/2021
1	Kidney Transplantation 01/2023
1	Blood Transfusion (Blood Transfusions) 01/2023
1	Catheters 12/2021
1	Oral Administration 02/2021